Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Treatment of advanced Parkinson's disease by subthalamotomy: One‐year results

Identifieur interne : 003F07 ( Main/Exploration ); précédent : 003F06; suivant : 003F08

Treatment of advanced Parkinson's disease by subthalamotomy: One‐year results

Auteurs : Philip C. Su [République populaire de Chine] ; Ham-Min Tseng [République populaire de Chine] ; Hon-Man Liu [République populaire de Chine] ; Ruoh-Fang Yen [République populaire de Chine] ; Horng-Huei Liou [République populaire de Chine]

Source :

RBID : ISTEX:B54D1CD39D66C367B007F609C001962141869B62

Descripteurs français

English descriptors

Abstract

We studied effects on parkinsonian features at 6 and 12 months in 12 patients who underwent unilateral ablation of subthalamic nucleus (STN). Microelectrode mapping was used, and a lesion was created in the STN using thermal coagulation and confirmed with magnetic resonance imaging. At 6 months postoperatively, improvements were seen in several areas: 1) Unified Parkinson's Disease Rating Scales II and III (UPDRS II and III) scores, 30% in off period, 38% in on period; 2) Schwab and England Scale (S&E) score, 21%; and 3) on dyskinesia, 85%. Contralateral rigidity, bradykinesia, UPDRS II and III scores, and S&E scores remained improved at 12 months. Daily dosage of levodopa requirement was reduced by 42%. Axial motor features, gait, postural stability, off period tremor, and motor fluctuation improved at 6 and 12 months but showed a decline in benefits at 18 months. Complications include 3 cases of hemiballism, of whom 2 patients recovered spontaneously but 1 died from aspiration pneumonia. One patient had asymptomatic hematoma, and 2 suffered transient postural asymmetries. We conclude that unilateral subthalamotomy results in moderate improvement in all aspects of parkinsonian features, allows reduction in the dose of levodopa required, and ameliorates drug‐induced complications throughout 12‐month assessments. © 2003 Movement Disorder Society

Url:
DOI: 10.1002/mds.10393


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Treatment of advanced Parkinson's disease by subthalamotomy: One‐year results</title>
<author>
<name sortKey="Su, Philip C" sort="Su, Philip C" uniqKey="Su P" first="Philip C." last="Su">Philip C. Su</name>
</author>
<author>
<name sortKey="Tseng, Ham In" sort="Tseng, Ham In" uniqKey="Tseng H" first="Ham-Min" last="Tseng">Ham-Min Tseng</name>
</author>
<author>
<name sortKey="Liu, Hon An" sort="Liu, Hon An" uniqKey="Liu H" first="Hon-Man" last="Liu">Hon-Man Liu</name>
</author>
<author>
<name sortKey="Yen, Ruoh Ang" sort="Yen, Ruoh Ang" uniqKey="Yen R" first="Ruoh-Fang" last="Yen">Ruoh-Fang Yen</name>
</author>
<author>
<name sortKey="Liou, Horng Uei" sort="Liou, Horng Uei" uniqKey="Liou H" first="Horng-Huei" last="Liou">Horng-Huei Liou</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B54D1CD39D66C367B007F609C001962141869B62</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10393</idno>
<idno type="url">https://api.istex.fr/document/B54D1CD39D66C367B007F609C001962141869B62/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000577</idno>
<idno type="wicri:Area/Istex/Curation">000577</idno>
<idno type="wicri:Area/Istex/Checkpoint">002836</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Su P:treatment:of:advanced</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12722167</idno>
<idno type="wicri:Area/PubMed/Corpus">003793</idno>
<idno type="wicri:Area/PubMed/Curation">003793</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003603</idno>
<idno type="wicri:Area/Ncbi/Merge">000A58</idno>
<idno type="wicri:Area/Ncbi/Curation">000A58</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000A58</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Su P:treatment:of:advanced</idno>
<idno type="wicri:Area/Main/Merge">005B29</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:03-0381007</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002450</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000871</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002290</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Su P:treatment:of:advanced</idno>
<idno type="wicri:Area/Main/Merge">005E36</idno>
<idno type="wicri:Area/Main/Curation">003F07</idno>
<idno type="wicri:Area/Main/Exploration">003F07</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Treatment of advanced Parkinson's disease by subthalamotomy: One‐year results</title>
<author>
<name sortKey="Su, Philip C" sort="Su, Philip C" uniqKey="Su P" first="Philip C." last="Su">Philip C. Su</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tseng, Ham In" sort="Tseng, Ham In" uniqKey="Tseng H" first="Ham-Min" last="Tseng">Ham-Min Tseng</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Neurosurgery, National Taiwan University Hospital, Taipei, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Liu, Hon An" sort="Liu, Hon An" uniqKey="Liu H" first="Hon-Man" last="Liu">Hon-Man Liu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Radiology, National Taiwan University Hospital, Taipei, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yen, Ruoh Ang" sort="Yen, Ruoh Ang" uniqKey="Yen R" first="Ruoh-Fang" last="Yen">Ruoh-Fang Yen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Liou, Horng Uei" sort="Liou, Horng Uei" uniqKey="Liou H" first="Horng-Huei" last="Liou">Horng-Huei Liou</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2003-05">2003-05</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="531">531</biblScope>
<biblScope unit="page" to="538">538</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">B54D1CD39D66C367B007F609C001962141869B62</idno>
<idno type="DOI">10.1002/mds.10393</idno>
<idno type="ArticleID">MDS10393</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Dyskinesias (diagnosis)</term>
<term>Dyskinesias (epidemiology)</term>
<term>Electrocoagulation</term>
<term>Female</term>
<term>Follow up study</term>
<term>Follow-Up Studies</term>
<term>Human</term>
<term>Humans</term>
<term>Hypokinesia (diagnosis)</term>
<term>Levodopa (therapeutic use)</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Microelectrodes</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (surgery)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Postoperative Complications</term>
<term>Posture</term>
<term>Questionnaires</term>
<term>Severity of Illness Index</term>
<term>Subthalamic Nucleus (pathology)</term>
<term>Subthalamic Nucleus (surgery)</term>
<term>Subthalamic nucleus</term>
<term>Surgery</term>
<term>Time</term>
<term>Treatment</term>
<term>Unilateral</term>
<term>hemiballism</term>
<term>microelectrode</term>
<term>subthalamic nucleus</term>
<term>subthalamotomy</term>
<term>surgical ablative therapy</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Dyskinesias</term>
<term>Hypokinesia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Dyskinesias</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Subthalamic Nucleus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Parkinson Disease</term>
<term>Subthalamic Nucleus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Electrocoagulation</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Microelectrodes</term>
<term>Middle Aged</term>
<term>Postoperative Complications</term>
<term>Posture</term>
<term>Questionnaires</term>
<term>Severity of Illness Index</term>
<term>Time</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Chirurgie</term>
<term>Etude longitudinale</term>
<term>Homme</term>
<term>Noyau sousthalamique</term>
<term>Parkinson maladie</term>
<term>Traitement</term>
<term>Unilatéral</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Chirurgie</term>
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We studied effects on parkinsonian features at 6 and 12 months in 12 patients who underwent unilateral ablation of subthalamic nucleus (STN). Microelectrode mapping was used, and a lesion was created in the STN using thermal coagulation and confirmed with magnetic resonance imaging. At 6 months postoperatively, improvements were seen in several areas: 1) Unified Parkinson's Disease Rating Scales II and III (UPDRS II and III) scores, 30% in off period, 38% in on period; 2) Schwab and England Scale (S&E) score, 21%; and 3) on dyskinesia, 85%. Contralateral rigidity, bradykinesia, UPDRS II and III scores, and S&E scores remained improved at 12 months. Daily dosage of levodopa requirement was reduced by 42%. Axial motor features, gait, postural stability, off period tremor, and motor fluctuation improved at 6 and 12 months but showed a decline in benefits at 18 months. Complications include 3 cases of hemiballism, of whom 2 patients recovered spontaneously but 1 died from aspiration pneumonia. One patient had asymptomatic hematoma, and 2 suffered transient postural asymmetries. We conclude that unilateral subthalamotomy results in moderate improvement in all aspects of parkinsonian features, allows reduction in the dose of levodopa required, and ameliorates drug‐induced complications throughout 12‐month assessments. © 2003 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Su, Philip C" sort="Su, Philip C" uniqKey="Su P" first="Philip C." last="Su">Philip C. Su</name>
</noRegion>
<name sortKey="Liou, Horng Uei" sort="Liou, Horng Uei" uniqKey="Liou H" first="Horng-Huei" last="Liou">Horng-Huei Liou</name>
<name sortKey="Liu, Hon An" sort="Liu, Hon An" uniqKey="Liu H" first="Hon-Man" last="Liu">Hon-Man Liu</name>
<name sortKey="Tseng, Ham In" sort="Tseng, Ham In" uniqKey="Tseng H" first="Ham-Min" last="Tseng">Ham-Min Tseng</name>
<name sortKey="Yen, Ruoh Ang" sort="Yen, Ruoh Ang" uniqKey="Yen R" first="Ruoh-Fang" last="Yen">Ruoh-Fang Yen</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F07 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003F07 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B54D1CD39D66C367B007F609C001962141869B62
   |texte=   Treatment of advanced Parkinson's disease by subthalamotomy: One‐year results
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024